New and more invasive procedures (e.g., spinal tap for the detection of biomarkers of AD—Aβ42, phosphorylated tau, and total tau—in the CSF) are now available to improve diagnostic accuracy, but not necessarily incorporated in the routine clinical practice or reimbursed appropriately (18, 43, 44). Here, MAPT is linked to Alzheimer disease.